{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:44:32Z","timestamp":1794041072347,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007209"],"award-info":[{"award-number":["T32DA007209"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/05p26gw61","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA03889"],"award-info":[{"award-number":["R01DA03889"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/05p26gw61","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","id":[{"id":"https:\/\/ror.org\/05p26gw61","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Heffter Research Institute, Steven and Alexandra Cohen Foundation, Tim Ferriss, Blake Mycoskie, Matt Mullenweg, Craig Nerenberg, the Riverstyx Foundation, and Dave Morin.","id":[{"id":"https:\/\/ror.org\/04ns7ha44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psilocybin has shown promise for the treatment of mood disorders, which are often accompanied by cognitive dysfunction including cognitive rigidity. Recent studies have proposed neuropsychoplastogenic effects as mechanisms underlying the enduring therapeutic effects of psilocybin. In an open-label study of 24 patients with major depressive disorder, we tested the enduring effects of psilocybin therapy on cognitive flexibility (perseverative errors on a set-shifting task), neural flexibility (dynamics of functional connectivity or dFC via functional magnetic resonance imaging), and neurometabolite concentrations (via magnetic resonance spectroscopy) in brain regions supporting cognitive flexibility and implicated in acute psilocybin effects (e.g., the anterior cingulate cortex, or ACC). Psilocybin therapy increased cognitive flexibility for at least 4 weeks post-treatment, though these improvements were not correlated with the previously reported antidepressant effects. One week after psilocybin therapy, glutamate and\n                    <jats:italic>N<\/jats:italic>\n                    -acetylaspartate concentrations were decreased in the ACC, and dFC was increased between the ACC and the posterior cingulate cortex (PCC). Surprisingly, greater increases in dFC between the ACC and PCC were associated with less improvement in cognitive flexibility after psilocybin therapy. Connectome-based predictive modeling demonstrated that baseline dFC emanating from the ACC predicted improvements in cognitive flexibility. In these models, greater baseline dFC was associated with better baseline cognitive flexibility but less improvement in cognitive flexibility. These findings suggest a nuanced relationship between cognitive and neural flexibility. Whereas some enduring increases in neural dynamics may allow for shifting out of a maladaptively rigid state, larger persisting increases in neural dynamics may be of less benefit to psilocybin therapy.\n                  <\/jats:p>","DOI":"10.1038\/s41398-021-01706-y","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T14:02:45Z","timestamp":1636380165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":338,"title":["Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2939-2522","authenticated-orcid":false,"given":"Manoj K.","family":"Doss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pova\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-4025","authenticated-orcid":false,"given":"Monica D.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Sepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-5440","authenticated-orcid":false,"given":"Gwenn S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Pekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-7793","authenticated-orcid":false,"given":"Peter B.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5185-7854","authenticated-orcid":false,"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa P, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29:289\u201399.","journal-title":"J Psychopharmacol"},{"key":"1706_CR2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016;3:619\u201327.","journal-title":"Lancet Psychiatry"},{"key":"1706_CR3","doi-asserted-by":"publisher","unstructured":"Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2020. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3285.","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"1706_CR4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30:1181\u201397.","journal-title":"J Psychopharmacol"},{"key":"1706_CR5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014;28:983\u201392.","journal-title":"J Psychopharmacol"},{"key":"1706_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","volume":"67","author":"FA Moreno","year":"2006","unstructured":"Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry. 2006;67:1735\u201340.","journal-title":"J Clin Psychiatry"},{"key":"1706_CR7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, et al. Trial of psilocybin versus escitalopram for depression. N. Engl J Med. 2021;384:1402\u201311.","journal-title":"N. Engl J Med"},{"key":"1706_CR8","doi-asserted-by":"publisher","unstructured":"Uddin LQ Cognitive and behavioural flexibility: neural mechanisms and clinical considerations. Nat Rev Neurosci. 2021. https:\/\/doi.org\/10.1038\/s41583-021-00428-w.","DOI":"10.1038\/s41583-021-00428-w"},{"key":"1706_CR9","first-page":"245","volume":"24","author":"JP Stange","year":"2017","unstructured":"Stange JP, Alloy LB, Fresco DM. Inflexibility as a vulnerability to depression: a systematic qualitative review. Clin Psychol: Sci Pract. 2017;24:245\u201376.","journal-title":"Clin Psychol: Sci Pract"},{"key":"1706_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-0327(96)00027-4","volume":"39","author":"S Channon","year":"1996","unstructured":"Channon S. Executive dysfunction in depression: The Wisconsin Card Sorting Test. J Affect Disord. 1996;39:107\u201314.","journal-title":"J Affect Disord"},{"key":"1706_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroscience.2016.07.030","volume":"345","author":"P Gruner","year":"2017","unstructured":"Gruner P, Pittenger C. Cognitive inflexibility in obsessive-compulsive disorder. Neuroscience. 2017;345:243\u201355.","journal-title":"Neuroscience"},{"key":"1706_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjp.bp.114.152223","volume":"207","author":"A Verdejo-Garcia","year":"2015","unstructured":"Verdejo-Garcia A, Clark L, Verdejo-Rom\u00e1n J, Albein-Urios N, Martinez-Gonzalez JM, Gutierrez B, et al. Neural substrates of cognitive flexibility in cocaine and gambling addictions. Br J Psychiatry. 2015;207:158\u201364.","journal-title":"Br J Psychiatry"},{"key":"1706_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000508682","volume":"80","author":"MM Maramis","year":"2021","unstructured":"Maramis MM, Mahajudin MS, Khotib J. Impaired cognitive flexibility and working memory precedes depression: a rat model to study depression. Neuropsychobiology. 2021;80:225\u201333.","journal-title":"Neuropsychobiology"},{"key":"1706_CR14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11065-020-09436-6","volume":"30","author":"VM Dotson","year":"2020","unstructured":"Dotson VM, McClintock SM, Verhaeghen P, Kim JU, Draheim AA, Syzmkowicz SM, et al. Depression and cognitive control across the lifespan: a systematic review and meta-analysis. Neuropsychol Rev. 2020;30:461\u201376.","journal-title":"Neuropsychol Rev"},{"key":"1706_CR15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11065-018-9373-9","volume":"28","author":"J Goodall","year":"2018","unstructured":"Goodall J, Fisher C, Hetrick S, Phillips L, Parrish EM, Allott K. Neurocognitive functioning in depressed young people: a systematic review and meta-analysis. Neuropsychol Rev. 2018;28:216\u201331.","journal-title":"Neuropsychol Rev"},{"key":"1706_CR16","doi-asserted-by":"crossref","first-page":"113931","DOI":"10.1016\/j.psychres.2021.113931","volume":"300","author":"H Liu","year":"2021","unstructured":"Liu H, Funkhouser CJ, Langenecker SA, Shankman SA. Set shifting and inhibition deficits as potential endophenotypes for depression. Psychiatry Res. 2021;300:113931.","journal-title":"Psychiatry Res"},{"key":"1706_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/627863","volume":"2014","author":"TL Greer","year":"2014","unstructured":"Greer TL, Sunderajan P, Grannemann BD, Kurian BT, Trivedi MH. Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction? Depression Res Treat. 2014;2014:1\u201313.","journal-title":"Depression Res Treat"},{"key":"1706_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brat.2014.04.005","volume":"57","author":"C Johnco","year":"2014","unstructured":"Johnco C, Wuthrich VM, Rapee RM. The influence of cognitive flexibility on treatment outcome and cognitive restructuring skill acquisition during cognitive behavioural treatment for anxiety and depression in older adults: results of a pilot study. Behav Res Ther. 2014;57:55\u201364.","journal-title":"Behav Res Ther"},{"key":"1706_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","volume":"15","author":"AK Davis","year":"2020","unstructured":"Davis AK, Barrett FS, Griffiths RR. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. J Contextual Behav Sci. 2020;15:39\u201345.","journal-title":"J Contextual Behav Sci"},{"key":"1706_CR20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jad.2020.08.058","volume":"277","author":"PR Shiroma","year":"2020","unstructured":"Shiroma PR, Thuras P, Wels J, Albott CS, Erbes C, Tye S, et al. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord. 2020;277:470\u20137.","journal-title":"J Affect Disord"},{"key":"1706_CR21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S0033291703007682","volume":"33","author":"MMA Nielen","year":"2003","unstructured":"Nielen MMA, Den Boer JA. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits. Psychol Med. 2003;33:917\u201325.","journal-title":"Psychol Med"},{"key":"1706_CR22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/mds.20508","volume":"20","author":"PS Boggio","year":"2005","unstructured":"Boggio PS, Fregni F, Bermpohl F, Mansur CG, Rosa M, Rumi DO, et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson\u2019s disease and concurrent depression. Mov Disord. 2005;20:1178\u201384.","journal-title":"Mov Disord"},{"key":"1706_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HTR.0b013e3181d6c715","volume":"25","author":"JH Ba\u00f1os","year":"2010","unstructured":"Ba\u00f1os JH, Novack TA, Brunner R, Renfroe S, Lin H-Y, Meythaler J. Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury. J Head Trauma Rehabilitation. 2010;25:357\u201361.","journal-title":"J Head Trauma Rehabilitation"},{"key":"1706_CR24","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s00213-015-3957-3","volume":"232","author":"JD Jett","year":"2015","unstructured":"Jett JD, Boley AM, Girotti M, Shah A, Lodge DJ, Morilak DA. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway. Psychopharmacology. 2015;232:3123\u201333.","journal-title":"Psychopharmacology"},{"key":"1706_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0269881118754733","volume":"32","author":"S Marwari","year":"2018","unstructured":"Marwari S, Dawe GS. (R)-fluoxetine enhances cognitive flexibility and hippocampal cell proliferation in mice. J Psychopharmacol. 2018;32:441\u201357.","journal-title":"J Psychopharmacol."},{"key":"1706_CR26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2010.80","volume":"16","author":"G MacQueen","year":"2011","unstructured":"MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry. 2011;16:252\u201364.","journal-title":"Mol Psychiatry"},{"key":"1706_CR27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-021-03272-1","volume":"591","author":"AJ Park","year":"2021","unstructured":"Park AJ, Harris AZ, Martyniuk KM, Chang C-Y, Abbas AI, Lowes DC, et al. Reset of hippocampal\u2013prefrontal circuitry facilitates learning. Nature. 2021;591:615\u20139.","journal-title":"Nature"},{"key":"1706_CR28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/a0028727","volume":"139","author":"HR Snyder","year":"2013","unstructured":"Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychological Bull. 2013;139:81\u2013132.","journal-title":"Psychological Bull"},{"key":"1706_CR29","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029\u201340.","journal-title":"Psychol Med"},{"key":"1706_CR30","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","volume":"33","author":"V Boulougouris","year":"2008","unstructured":"Boulougouris V, Glennon JC, Robbins TW. Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacol. 2008;33:2007\u201319.","journal-title":"Neuropsychopharmacol"},{"key":"1706_CR31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S1461145711001441","volume":"15","author":"A Furr","year":"2012","unstructured":"Furr A, Lapiz-Bluhm MD, Morilak DA. 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. Int J Neuropsychopharm. 2012;15:1295\u2013305.","journal-title":"Int J Neuropsychopharm"},{"key":"1706_CR32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/gbb.12343","volume":"16","author":"DA Amodeo","year":"2017","unstructured":"Amodeo DA, Rivera E, Cook EH, Sweeney JA, Ragozzino ME. 5HT 2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice: striatal 5HT 2A blockade improves repetitive behaviors. Genes, Brain Behav. 2017;16:342\u201351.","journal-title":"Genes, Brain Behav"},{"key":"1706_CR33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/aur.1395","volume":"7","author":"DA Amodeo","year":"2014","unstructured":"Amodeo DA, Jones JH, Sweeney JA, Ragozzino ME. Risperidone and the 5-HT 2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf\/J mice: 5HT 2A receptor blockade improves reversal learning in BTBR mice. Autism Res. 2014;7:555\u201367.","journal-title":"Autism Res"},{"key":"1706_CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2010.12.031","volume":"219","author":"PM Baker","year":"2011","unstructured":"Baker PM, Thompson JL, Sweeney JA, Ragozzino ME. Differential effects of 5-HT2A and 5-HT2C receptor blockade on strategy-switching. Behavioural Brain Res. 2011;219:123\u201331.","journal-title":"Behavioural Brain Res"},{"key":"1706_CR35","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1017\/S0033291719002393","volume":"50","author":"T Pokorny","year":"2020","unstructured":"Pokorny T, Duerler P, Seifritz E, Vollenweider FX, Preller KH. LSD acutely impairs working memory executive functions and cognitive flexibility but not risk-based decision-making. Psychol Med. 2020;50:2255\u201364. https:\/\/doi.org\/10.1017\/S0033291719002393.","journal-title":"Psychol Med"},{"key":"1706_CR36","doi-asserted-by":"crossref","first-page":"112861","DOI":"10.1016\/j.bbr.2020.112861","volume":"395","author":"DA Amodeo","year":"2020","unstructured":"Amodeo DA, Hassan O, Klein L, Halberstadt AL, Powell SB. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice. Behavioural Brain Res. 2020;395:112861.","journal-title":"Behavioural Brain Res"},{"key":"1706_CR37","doi-asserted-by":"publisher","unstructured":"Odland AU, Kristensen JL, Andreasen JT. The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice. Behav Pharmacol. 2021. https:\/\/doi.org\/10.1097\/FBP.0000000000000626.","DOI":"10.1097\/FBP.0000000000000626"},{"key":"1706_CR38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1523\/JNEUROSCI.4312-09.2010","volume":"30","author":"V Boulougouris","year":"2010","unstructured":"Boulougouris V, Robbins TW. Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. J Neurosci. 2010;30:930\u20138.","journal-title":"J Neurosci"},{"key":"1706_CR39","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1162\/jocn_a_01536","volume":"32","author":"DR Dajani","year":"2020","unstructured":"Dajani DR, Odriozola P, Winters M, Voorhies W, Marcano S, Baez A, et al. Measuring cognitive flexibility with the flexible item selection task: from fMRI adaptation to individual connectome mapping. J Cogn Neurosci. 2020;32:1026\u201345.","journal-title":"J Cogn Neurosci"},{"key":"1706_CR40","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/cercor\/bhp247","volume":"20","author":"DG Ghahremani","year":"2010","unstructured":"Ghahremani DG, Monterosso J, Jentsch JD, Bilder RM, Poldrack RA. Neural components underlying behavioral flexibility in human reversal learning. Cereb Cortex. 2010;20:1843\u201352.","journal-title":"Cereb Cortex"},{"key":"1706_CR41","doi-asserted-by":"crossref","unstructured":"Cohen Y, Schneidman E, Paz R. The geometry of neuronal representations during rule learning reveals complementary roles of cingulate cortex and putamen. Neuron. 2021: S089662732031031X.","DOI":"10.1016\/j.neuron.2020.12.027"},{"key":"1706_CR42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","volume":"16","author":"F Vollenweider","year":"1997","unstructured":"Vollenweider F. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology. 1997;16:357\u201372.","journal-title":"Neuropsychopharmacology"},{"key":"1706_CR43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","volume":"20","author":"E Gouzoulis-Mayfrank","year":"1999","unstructured":"Gouzoulis-Mayfrank E. Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology. 1999;20:565\u201381.","journal-title":"Neuropsychopharmacology"},{"key":"1706_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-006-0358-7","volume":"186","author":"J Riba","year":"2006","unstructured":"Riba J, Romero S, Grasa E, Mena E, Carri\u00f3 I, Barbanoj MJ. Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant. Psychopharmacology. 2006;186:93\u201398.","journal-title":"Psychopharmacology"},{"key":"1706_CR45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","volume":"39","author":"RL Carhart-Harris","year":"2013","unstructured":"Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, et al. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophrenia Bull. 2013;39:1343\u201351.","journal-title":"Schizophrenia Bull"},{"key":"1706_CR46","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci USA. 2016;113:4853\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1706_CR47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","volume":"18","author":"F M\u00fcller","year":"2018","unstructured":"M\u00fcller F, Dolder PC, Schmidt A, Liechti ME, Borgwardt S. Altered network hub connectivity after acute LSD administration. NeuroImage: Clin. 2018;18:694\u2013701.","journal-title":"NeuroImage: Clin"},{"key":"1706_CR48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/0269881120909409","volume":"34","author":"L Pasquini","year":"2020","unstructured":"Pasquini L, Palhano-Fontes F, Araujo DB. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. J Psychopharmacol. 2020;34:623\u201335.","journal-title":"J Psychopharmacol"},{"key":"1706_CR49","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","volume":"20","author":"F Sampedro","year":"2017","unstructured":"Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Dom\u00ednguez-Clav\u00e9 E, Elices M, et al. Assessing the psychedelic \u201cafter-glow\u201d in Ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol. 2017;20:698\u2013711.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1706_CR50","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","volume":"109","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA. 2012;109:2138\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1706_CR51","doi-asserted-by":"crossref","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","volume":"10","author":"F Palhano-Fontes","year":"2015","unstructured":"Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JAS, Hallak JEC, et al. The psychedelic state induced by Ayahuasca modulates the activity and connectivity of the default mode network. PLoS ONE. 2015;10:e0118143.","journal-title":"PLoS ONE"},{"key":"1706_CR52","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","volume":"116","author":"KH Preller","year":"2019","unstructured":"Preller KH, Razi A, Zeidman P, St\u00e4mpfli P, Friston KJ, Vollenweider FX. Effective connectivity changes in LSD-induced altered states of consciousness in humans. Proc Natl Acad Sci USA. 2019;116:2743\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1706_CR53","doi-asserted-by":"publisher","unstructured":"Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, et al. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci Rep. 2017;7. https:\/\/doi.org\/10.1038\/s41598-017-13282-7.","DOI":"10.1038\/s41598-017-13282-7"},{"key":"1706_CR54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2010.09.034","volume":"69","author":"C Hamani","year":"2011","unstructured":"Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM. The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry. 2011;69:301\u20138.","journal-title":"Biol Psychiatry"},{"key":"1706_CR55","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jad.2019.01.040","volume":"249","author":"J Schwartz","year":"2019","unstructured":"Schwartz J, Ordaz SJ, Kircanski K, Ho TC, Davis EG, Camacho MC, et al. Resting-state functional connectivity and inflexibility of daily emotions in major depression. J Affect Disord. 2019;249:26\u201334.","journal-title":"J Affect Disord"},{"key":"1706_CR56","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170\u201382.","journal-title":"Cell Rep."},{"key":"1706_CR57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1075-9","volume":"569","author":"R Nardou","year":"2019","unstructured":"Nardou R, Lewis EM, Rothhaas R, Xu R, Yang A, Boyden E, et al. Oxytocin-dependent reopening of a social reward learning critical period with MDMA. Nature. 2019;569:116\u201320.","journal-title":"Nature"},{"key":"1706_CR58","volume":"10","author":"JA Morales-Garcia","year":"2020","unstructured":"Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA, Alonso-Gil S, Sanz-SanCristobal M, Riba J, et al. N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Transl Psychiatry. 2020;10:331.","journal-title":"Transl Psychiatry"},{"key":"1706_CR59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","volume":"228","author":"BJ Catlow","year":"2013","unstructured":"Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J. Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Exp Brain Res. 2013;228:481\u201391.","journal-title":"Exp Brain Res"},{"key":"1706_CR60","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","volume":"589","author":"LP Cameron","year":"2021","unstructured":"Cameron LP, Tombari RJ, Lu J, Pell AJ, Hurley ZQ, Ehinger Y, et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature. 2021;589:474\u20139.","journal-title":"Nature"},{"key":"1706_CR61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","volume":"73","author":"A Inserra","year":"2021","unstructured":"Inserra A, De Gregorio D, Gobbi G. Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms. Pharm Rev. 2021;73:202\u201377.","journal-title":"Pharm Rev"},{"key":"1706_CR62","doi-asserted-by":"crossref","first-page":"117906951880050","DOI":"10.1177\/1179069518800508","volume":"12","author":"DE Olson","year":"2018","unstructured":"Olson DE. sychoplastogens: A promising class of plasticity-promoting neurotherapeutics. J Exp Neurosci. 2018;12:117906951880050.","journal-title":"J Exp Neurosci"},{"key":"1706_CR63","doi-asserted-by":"crossref","first-page":"e1002469","DOI":"10.1371\/journal.pbio.1002469","volume":"14","author":"T Chen","year":"2016","unstructured":"Chen T, Cai W, Ryali S, Supekar K, Menon V. Distinct global brain dynamics and spatiotemporal organization of the salience network. PLoS Biol. 2016;14:e1002469.","journal-title":"PLoS Biol"},{"key":"1706_CR64","doi-asserted-by":"crossref","unstructured":"Waschke L, Kloosterman NA, Obleser J, Garrett DD. Behavior needs neural variability. Neuron. 2021: S0896627321000453.","DOI":"10.1016\/j.neuron.2021.01.023"},{"key":"1706_CR65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jad.2017.11.026","volume":"227","author":"H Zheng","year":"2018","unstructured":"Zheng H, Li F, Bo Q, Li X, Yao L, Yao Z, et al. The dynamic characteristics of the anterior cingulate cortex in resting-state fMRI of patients with depression. J Affect Disord. 2018;227:391\u20137.","journal-title":"J Affect Disord"},{"key":"1706_CR66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jad.2019.03.012","volume":"250","author":"C Lin","year":"2019","unstructured":"Lin C, Lee S-H, Huang C-M, Chen G-Y, Ho P-S, Liu H-L, et al. Increased brain entropy of resting-state fMRI mediates the relationship between depression severity and mental health-related quality of life in late-life depressed elderly. J Affect Disord. 2019;250:270\u20137.","journal-title":"J Affect Disord"},{"key":"1706_CR67","doi-asserted-by":"crossref","first-page":"12568","DOI":"10.1073\/pnas.1608819113","volume":"113","author":"U Braun","year":"2016","unstructured":"Braun U, Sch\u00e4fer A, Bassett DS, Rausch F, Schweiger JI, Bilek E, et al. Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function. Proc Natl Acad Sci USA. 2016;113:12568\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1706_CR68","doi-asserted-by":"publisher","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, et al. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Human Neurosci. 2014;8. https:\/\/doi.org\/10.3389\/fnhum.2014.00020.","DOI":"10.3389\/fnhum.2014.00020"},{"key":"1706_CR69","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/hbm.23234","volume":"37","author":"AV Lebedev","year":"2016","unstructured":"Lebedev AV, Kaelen M, L\u00f6vd\u00e9n M, Nilsson J, Feilding A, Nutt DJ, et al. LSD-induced entropic brain activity predicts subsequent personality change: LSD-induced entropic brain activity. Hum Brain Mapp. 2016;37:3203\u201313.","journal-title":"Hum Brain Mapp"},{"key":"1706_CR70","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1002\/hbm.22562","volume":"35","author":"E Tagliazucchi","year":"2014","unstructured":"Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR. Enhanced repertoire of brain dynamical states during the psychedelic experience: Enhanced Repertoire of Brain Dynamical States. Hum Brain Mapp. 2014;35:5442\u201356.","journal-title":"Hum Brain Mapp"},{"key":"1706_CR71","doi-asserted-by":"publisher","unstructured":"Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, et al. The acute effects of the atypical dissociative hallucinogen salvinorin A on functional connectivity in the human brain. Sci Rep. 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-73216-8.","DOI":"10.1038\/s41598-020-73216-8"},{"key":"1706_CR72","doi-asserted-by":"publisher","unstructured":"Spies M, Kl\u00f6bl M, H\u00f6flich A, Hummer A, Vanicek T, Michenthaler P, et al. Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks. Sci Rep. 2019;9. https:\/\/doi.org\/10.1038\/s41598-019-46702-x.","DOI":"10.1038\/s41598-019-46702-x"},{"key":"1706_CR73","doi-asserted-by":"publisher","unstructured":"Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep. 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-59282-y.","DOI":"10.1038\/s41598-020-59282-y"},{"key":"1706_CR74","first-page":"449","volume":"2","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Hannestad J, Mason GF, Holmes SE, DellaGioia N, Sanacora G, et al. Metabotropic glutamate receptor 5 and glutamate involvement in major depressive disorder: a multimodal imaging study. Biol Psychiatry: Cogn Neurosci Neuroimaging. 2017;2:449\u201356.","journal-title":"Biol Psychiatry: Cogn Neurosci Neuroimaging"},{"key":"1706_CR75","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1503\/jpn.150177","volume":"42","author":"S Njau","year":"2017","unstructured":"Njau S, Joshi SH, Espinoza R, Leaver AM, Vasavada M, Marquina A, et al. Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression. JPN. 2017;42:6\u201316.","journal-title":"JPN"},{"key":"1706_CR76","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jad.2020.10.011","volume":"279","author":"GS Smith","year":"2021","unstructured":"Smith GS, Oeltzschner G, Gould NF, Leoutsakos J-MS, Nassery N, Joo JH, et al. Neurotransmitters and neurometabolites in late-life depression: a preliminary magnetic resonance spectroscopy study at 7T. J Affect Disord. 2021;279:417\u201325.","journal-title":"J Affect Disord"},{"key":"1706_CR77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YIC.0b013e3282f948f5","volume":"23","author":"JBW Williams","year":"2008","unstructured":"Williams JBW, Kobak KA, Bech P, Engelhardt N, Evans K, Lipsitz J, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol. 2008;23:120\u20139.","journal-title":"Int Clin Psychopharmacol"},{"key":"1706_CR78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0887-6177(03)00003-9","volume":"19","author":"M Kurtz","year":"2004","unstructured":"Kurtz M. The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms for repeat administration. Arch Clin Neuropsychol. 2004;19:191\u2013201.","journal-title":"Arch Clin Neuropsychol"},{"key":"1706_CR79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00221309.1948.9918159","volume":"39","author":"EA Berg","year":"1948","unstructured":"Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948;39:15\u201322.","journal-title":"J Gen Psychol"},{"key":"1706_CR80","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1002\/hbm.23737","volume":"38","author":"VD Calhoun","year":"2017","unstructured":"Calhoun VD, Wager TD, Krishnan A, Rosch KS, Seymour KE, Nebel MB, et al. The impact of T1 versus EPI spatial normalization templates for fMRI data analyses: impact of T1 vs EPI spatial normalization templates. Hum Brain Mapp. 2017;38:5331\u201342.","journal-title":"Hum Brain Mapp"},{"key":"1706_CR81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroimage.2007.04.042","volume":"37","author":"Y Behzadi","year":"2007","unstructured":"Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage. 2007;37:90\u2013101.","journal-title":"NeuroImage"},{"key":"1706_CR82","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroimage.2012.08.052","volume":"64","author":"TD Satterthwaite","year":"2013","unstructured":"Satterthwaite TD, Elliott MA, Gerraty RT, Ruparel K, Loughead J, Calkins ME, et al. An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data. NeuroImage. 2013;64:240\u201356.","journal-title":"NeuroImage"},{"key":"1706_CR83","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.neuroimage.2011.10.018","volume":"59","author":"JD Power","year":"2012","unstructured":"Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. NeuroImage. 2012;59:2142\u201354.","journal-title":"NeuroImage"},{"key":"1706_CR84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuron.2011.09.006","volume":"72","author":"JD Power","year":"2011","unstructured":"Power JD, Cohen AL, Nelson SM, Wig GS, Barnes KA, Church JA, et al. Functional network organization of the human brain. Neuron. 2011;72:665\u201378.","journal-title":"Neuron"},{"key":"1706_CR85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/mrm.26091","volume":"77","author":"R Simpson","year":"2017","unstructured":"Simpson R, Devenyi GA, Jezzard P, Hennessy TJ, Near J. Advanced processing and simulation of MRS data using the FID appliance (FID\u2010A)\u2014An open source, MATLAB \u2010based toolkit. Magn Reson Med. 2017;77:23\u201333.","journal-title":"Magn Reson Med"},{"key":"1706_CR86","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","volume":"14","author":"SW Provencher","year":"2001","unstructured":"Provencher SW. Automatic quantitation of localizedin vivo1H spectra with LCModel. NMR Biomed. 2001;14:260\u20134.","journal-title":"NMR Biomed"},{"key":"1706_CR87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18383\/j.tom.2016.00139","volume":"2","author":"A Berrington","year":"2016","unstructured":"Berrington A, Voets NL, Plaha P, Larkin SJ, Mccullagh J, Stacey R, et al. Improved localization for 2-hydroxyglutarate detection at 3 T using long-TE semi-LASER. Tomography. 2016;2:94\u2013105.","journal-title":"Tomography"},{"key":"1706_CR88","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuroimage.2014.06.052","volume":"101","author":"MA Lindquist","year":"2014","unstructured":"Lindquist MA, Xu Y, Nebel MB, Caffo BS. Evaluating dynamic bivariate correlations in resting-state fMRI: a comparison study and a new approach. NeuroImage. 2014;101:531\u201346.","journal-title":"NeuroImage"},{"key":"1706_CR89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuroimage.2017.07.005","volume":"158","author":"AS Choe","year":"2017","unstructured":"Choe AS, Nebel MB, Barber AD, Cohen JR, Xu Y, Pekar JJ, et al. Comparing test-retest reliability of dynamic functional connectivity methods. NeuroImage. 2017;158:155\u201375.","journal-title":"NeuroImage"},{"key":"1706_CR90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroimage.2018.11.057","volume":"188","author":"AHC Fong","year":"2019","unstructured":"Fong AHC, Yoo K, Rosenberg MD, Zhang S, Li C-SR, Scheinost D, et al. Dynamic functional connectivity during task performance and rest predicts individual differences in attention across studies. NeuroImage. 2019;188:14\u201325.","journal-title":"NeuroImage"},{"key":"1706_CR91","doi-asserted-by":"publisher","unstructured":"Goldfarb EV, Rosenberg MD, Seo D, Constable RT, Sinha R, Hippocampal seed connectome-based modeling predicts the feeling of stress. Nat Commun. 2020;11: https:\/\/doi.org\/10.1038\/s41467-020-16492-2.","DOI":"10.1038\/s41467-020-16492-2"},{"key":"1706_CR92","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nprot.2016.178","volume":"12","author":"X Shen","year":"2017","unstructured":"Shen X, Finn ES, Scheinost D, Rosenberg MD, Chun MM, Papademetris X, et al. Using connectome-based predictive modeling to predict individual behavior from brain connectivity. Nat Protoc. 2017;12:506\u201318.","journal-title":"Nat Protoc"},{"key":"1706_CR93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fpsyt.2018.00517","volume":"9","author":"MP Hengartner","year":"2018","unstructured":"Hengartner MP, Pl\u00f6derl M. Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work: effect size and method bias matter! Front Psychiatry. 2018;9:517.","journal-title":"Front Psychiatry"},{"key":"1706_CR94","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1345\/aph.1D172","volume":"37","author":"P Stolk","year":"2003","unstructured":"Stolk P, ten Berg MJ, Hemels ME, Einarson TR. Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother. 2003;37:1891\u20139.","journal-title":"Ann Pharmacother"},{"key":"1706_CR95","doi-asserted-by":"crossref","first-page":"e4040","DOI":"10.1002\/nbm.4040","volume":"32","author":"SA Wijtenburg","year":"2019","unstructured":"Wijtenburg SA, Rowland LM, Oeltzschner G, Barker PB, Workman CI, Smith GS. Reproducibility of brain MRS in older healthy adults at 7T. NMR Biomed. 2019;32:e4040.","journal-title":"NMR Biomed"},{"key":"1706_CR96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.2051-5545.2011.tb00061.x","volume":"10","author":"D Goldberg","year":"2011","unstructured":"Goldberg D. The heterogeneity of \u201cmajor depression\u201d. World Psychiatry. 2011;10:226\u20138.","journal-title":"World Psychiatry"},{"key":"1706_CR97","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1523\/JNEUROSCI.1746-16.2016","volume":"36","author":"MD Rosenberg","year":"2016","unstructured":"Rosenberg MD, Zhang S, Hsu W-T, Scheinost D, Finn ES, Shen X, et al. Methylphenidate modulates functional network connectivity to enhance attention. J Neurosci. 2016;36:9547\u201357.","journal-title":"J Neurosci"},{"key":"1706_CR98","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nn.4179","volume":"19","author":"MD Rosenberg","year":"2016","unstructured":"Rosenberg MD, Finn ES, Scheinost D, Papademetris X, Shen X, Constable RT, et al. A neuromarker of sustained attention from whole-brain functional connectivity. Nat Neurosci. 2016;19:165\u201371.","journal-title":"Nat Neurosci"},{"key":"1706_CR99","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1073\/pnas.1912226117","volume":"117","author":"MD Rosenberg","year":"2020","unstructured":"Rosenberg MD, Scheinost D, Greene AS, Avery EW, Kwon YH, Finn ES, et al. Functional connectivity predicts changes in attention observed across minutes, days, and months. Proc Natl Acad Sci USA. 2020;117:3797\u2013807.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1706_CR100","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/nn.2439","volume":"12","author":"MR Cohen","year":"2009","unstructured":"Cohen MR, Maunsell JHR. Attention improves performance primarily by reducing interneuronal correlations. Nat Neurosci. 2009;12:1594\u20131600.","journal-title":"Nat Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01706-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T10:32:59Z","timestamp":1669890779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01706-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01706-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MKD is on the scientific advisory board for Ocean Bio Limited. AKD is a board member of Source Research Foundation. PHF is on the scientific advisory board for and has an equity position in Ninnion Therapeutics. RRG is a board member of the Heffter Research Institute. FSB is an advisor to Wavepaths. All other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"574"}}